loadpatents
Patent applications and USPTO patent grants for Cunningham; Brian C..The latest application filed is for "vascular endothelial cell growth factor variants and uses thereof".
Patent | Date |
---|---|
Growth hormone variants Grant 8,637,646 - Wells , et al. January 28, 2 | 2014-01-28 |
Vascular Endothelial Cell Growth Factor Variants And Uses Thereof App 20070142284 - Cunningham; Brian C. ;   et al. | 2007-06-21 |
Vascular endothelial cell growth factor variants and uses thereof App 20060269997 - Cunningham; Brian C. ;   et al. | 2006-11-30 |
Vascular endothelial cell growth factor variants and uses thereof Grant 7,090,834 - Cunningham , et al. August 15, 2 | 2006-08-15 |
Vascular endothelial cell growth factor variants and uses thereof App 20060063203 - Cunningham; Brian C. ;   et al. | 2006-03-23 |
Selecting ligand agonists and antagonists Grant 6,936,440 - Cunningham , et al. August 30, 2 | 2005-08-30 |
Variants of native growth hormones having non naturally occurring amino acid sequences or covalent modifications Grant 6,800,740 - Cunningham , et al. October 5, 2 | 2004-10-05 |
Growth hormone variants Grant 6,780,613 - Wells , et al. August 24, 2 | 2004-08-24 |
Growth hormone variants App 20030153003 - Wells, James A. ;   et al. | 2003-08-14 |
Receptor specific atrial natriuretic peptides Grant 6,525,022 - Lowe , et al. February 25, 2 | 2003-02-25 |
Non-human carbonyl hydrolase mutants, DNA sequences and vectors encoding same and hosts transformed with said vectors Grant 6,465,235 - Bott , et al. October 15, 2 | 2002-10-15 |
Growth hormone variants Grant 6,451,561 - Wells , et al. September 17, 2 | 2002-09-17 |
Triphenyl compounds as interleukin-4 antagonists Grant 6,376,524 - Barr , et al. April 23, 2 | 2002-04-23 |
Human growth hormone variants Grant 6,143,523 - Cunningham , et al. November 7, 2 | 2000-11-07 |
Variants of vascular endothelial cell growth factor Grant 6,057,428 - Keyt , et al. May 2, 2 | 2000-05-02 |
Method for inhibiting growth hormone action Grant 6,057,292 - Cunningham , et al. May 2, 2 | 2000-05-02 |
Human growth hormone variants having enhanced affinity for human growth hormone receptor at site 1 Grant 6,022,711 - Cunningham , et al. February 8, 2 | 2000-02-08 |
Method for identifying active domains and amino acid residues in polypeptides and hormone variants Grant 6,013,478 - Wells , et al. January 11, 2 | 2000-01-11 |
Enzymatically active modified subtilisins Grant 5,972,682 - Bott , et al. October 26, 1 | 1999-10-26 |
Modified subtilisins having amino acid alterations Grant 5,955,340 - Bott , et al. September 21, 1 | 1999-09-21 |
Human growth hormone variants Grant 5,849,535 - Cunningham , et al. December 15, 1 | 1998-12-15 |
Receptor specific atrial natriuretic peptides Grant 5,846,932 - Lowe , et al. December 8, 1 | 1998-12-08 |
Method for identifying active domains and amino acid residues in polypeptides and hormone variants Grant 5,834,250 - Wells , et al. November 10, 1 | 1998-11-10 |
Modified subtilisins having amino acid alterations Grant 5,801,038 - Bott , et al. September 1, 1 | 1998-09-01 |
Modified subtilisins having amino acid alterations Grant 5,763,257 - Bott , et al. June 9, 1 | 1998-06-09 |
Modified subtilisins having amino acid alterations Grant 5,700,676 - Bott , et al. December 23, 1 | 1997-12-23 |
Receptor specific atrial natriuretic peptides Grant 5,665,704 - Lowe , et al. September 9, 1 | 1997-09-09 |
Method for identifying active domains and amino acid residues in polypeptides and hormone variants Grant 5,580,723 - Wells , et al. December 3, 1 | 1996-12-03 |
Human growth hormone variants having greater affinity for human growth hormone receptor at site 1 Grant 5,534,617 - Cunningham , et al. July 9, 1 | 1996-07-09 |
Selecting ligand agonists and antagonists Grant 5,506,107 - Cunningham , et al. April 9, 1 | 1996-04-09 |
Method for testing microbial degradation of cellulose Grant 4,506,010 - Goodman , et al. March 19, 1 | 1985-03-19 |
SEC | 0001190276 | CUNNINGHAM BRIAN C |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.